IMARC Group has recently released a report titled “Surgical Site Infections Market: Analysis of Epidemiology, Industry Trends, Size, Share, and Future Forecast (2023-2033)” that presents a comprehensive assessment of the surgical site infections market. The report provides an extensive overview of the latest market trends, growth prospects, investment opportunities, and industry outlook, as well as an in-depth analysis of the disease landscape, market scenario, and growth trends. Furthermore, the report offers an analysis of competitors, regional markets, and recent advancements in the global market. It also sheds light on crucial segments and market drivers, along with challenges faced by industry players. This report is a valuable resource for stakeholders who want to gain valuable insights into the surgical site infections market.

Surgical site infections (SSI) refer to medical complications that arise after surgery in the area of the body where the operation was conducted. It is primarily caused by the colonization of a surgical incision by infectious agents like bacteria or fungi. SSI manifests as either a superficial condition simply affecting the skin or as a severe infection damaging the organs, implanted materials, or tissues beneath the skin. Some of the common symptoms of this ailment include redness, pain, fever, delayed healing, tenderness, swelling, and the drainage of cloudy fluid or pus from the wound site. The diagnosis of surgical site infections involves a combination of the patient’s medical history, clinical features, laboratory studies, the collection of wound swabs to determine the presence of disease-causing microorganisms, and ultrasonography.

Request a Free Sample Report:

The growing instances of exogenous and endogenous infections caused by contamination of the operative site by microorganisms during the surgical procedure are primarily driving the surgical site infections market. Additionally, the rising cases of various risk-associated factors, such as increased surgical duration, certain co-morbidities like diabetes and cancer, a weakened immune system, etc., are further catalyzing the market growth. Moreover, the escalating utilization of antibiotic drugs, including cefazolin, metronidazole, vancomycin, clindamycin, etc., for treating the condition, as these medications destroy or slow down the proliferation of infection-causing microorganisms, is creating a positive outlook for the market.

Besides this, the rising popularity of combination therapies such as nasal mupirocin and a chlorhexidine body wash, owing to their ability to decolonize patients with bacterial growth and minimize the risk of microbial contamination, is anticipated to propel the surgical site infections market in the coming years.

Report Period:

  • Base Year: 2022
  • Historical Period: 2017-2022
  • Market Forecast: 2023-2033

Countries Included:

  • United States
  • Germany
  • France
  • United Kingdom
  • Italy
  • Spain
  • Japan

Analysis Covered Across Each Country

  • Historical, current, and future epidemiology scenario
  • Historical, current, and future performance of the surgical site infections market
  • Historical, current, and future performance of various therapeutic categories in the market
  • Sales of various drugs across the surgical site infections market
  • Reimbursement scenario in the market
  • In-market and pipeline drugs

In-Market Drugs

  • Drug Overview
  • Mechanism of Action
  • Regulatory Status
  • Clinical Trial Results
  • Drug Uptake and Market Performance

Late-Stage Pipeline Drugs

  • Drug Overview
  • Mechanism of Action
  • Regulatory Status
  • Clinical Trial Results
  • Regulatory Status

Ask an Analyst for Report Customization with TOC & List of figures:

Key Questions Answered in this Report:

  • How has the surgical site infections market performed so far and how will it perform in the coming years?
  • What are the markets shares of various therapeutic segments in 2022 and how are they expected to perform till 2033?
  • What was the country-wise size of the surgical site infections market across the seven major markets in 2022 and what will it look like in 2033?
  • What is the growth rate of the surgical site infections market across the seven major markets and what will be the expected growth over the next ten years?
  • What are the key unmet needs in the market?

Browse the Latest Research Report:

Avascular Necrosis Market Report 2023-2033

Deep Vein Thrombosis Market Report 2023-2033

Vulvovaginal Candidiasis Market Report 2023-2033

Sciatica Market Report 2023-2033

About Us: –

IMARC Group is a leading market research company that offers management strategy and market research worldwide. We partner with clients in all sectors and regions to identify their highest-value opportunities, address their most critical challenges, and transform their businesses.

IMARC’s information products include major market, scientific, economic and technological developments for business leaders in pharmaceutical, industrial, and high technology organizations. Market forecasts and industry analysis for biotechnology, advanced materials, pharmaceuticals, food and beverage, travel and tourism, nanotechnology and novel processing methods are at the top of the company’s expertise.

Contact US

134 N 4th St.
Brooklyn, NY 11249, USA
Americas:- +1 631 791 1145 | Africa and Europe :- +44-702-409-7331 | Asia: +91-120-433-0800, +91-120-433-0800